Yigit Kaya S, Mutlu YG, Malkan UY, Mehtap O, et al. Single agent vemurafenib or rituximab-vemurafenib combination for the treatment of relapsed/refractory hairy cell leukemia, a multicenter experience. Leuk Res 2024;140:107495.
PMID: 38599153